Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹2,202.90Admitted-Finance | ₹2,202.90 | L1 | Admitted-Finance |
| 2 | L2₹2,236.50+₹33.60 (1.53%)Admitted-Finance DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R 282 ITC AREA OF MIDC THANE BELAPUR ROAD RABALE NAVI MUMBAI 400701 | NAVI MUMBAI | THANE | MAHARASHTRA | 400701 | ₹2,236.50+₹33.60 (1.53%) | L2 | Admitted-Finance |
| 3 | Rejected-Technical | - | - | Rejected-Technical non responsive |
| Sl No | Description | Qty | Unit | PLASMAGEN BIOSCIENCES PVT LTD L1 | Reliance Life Sciences Pvt. Ltd. L2 |
|---|---|---|---|---|---|
| 1.00 | Hepatitis B Immunoglobulin HBIG 100 IU
Technical specification
1. Each injection contains hepatitis B Immunoglobulin 100 IU
2. Number of ml per vial: 0.5 ml
3. Should be licensed under the provisions of drugs and cosmetics act and rules.
4. The product insert must indicate dosage form (intramuscular injection) and the drug content. The product should conform to standards of IP or any other pharmacopeia.
5. The label must indicate clearly the manufacturing and the expiry date.
General specifications
1. Standard shelf life: atleast 18 months at the place of dispatch to the consignee.
2. Primary container: one vial/pre-filled syringe with 0.5 ml.
3. Label: It should be glazed label in accordance with the statutory requirements as per drug and cosmetic Act. The standard color of the label as approved by NVHCP should be used. Each label should have clearly marked as “ Government of India supply, not for sale” on primary packaging. The packaging and labeling requirements must meet the GMP practices.
4. It should be tested negative for HBV, HIV, HCV which will be printed on each unit packet. | 4,569 | Vial/PFS | 2,098 ₹2,202.9 Lowest | 2,130 ₹2,236.5 |
Tender Value
Refer Docs
EMD Value
₹5 L
Closing Date
18 Nov 2021, 6:00 pmClosed
MD, RMSCL
RMSCL, Swasthyabhawan, Tilak Marg, Jaipur
Drug and medicine
2021_RMSCL_242900_1
F02 335 RMSCL PROC DRUG NIB25 20211577 30.9.21
Open Tender
Supply of Materials/Hiring of Goods
Item Wise
60 days
all ddw mcdw and head quarter rajasthan
Manufacturing Licence, PP, MSC, NCC, GMP/WHO-GMP, Performance Statement, Turn Over, Bid Security, RISL Fees, Bid Forms Fees And All Annexure, Etc
4 documents required · 4 mandatory
₹2,000
MD, RMSCL
₹5 L
Yes
Meeting Hall, RMSCL
15 Feb 2022
30 Sept 2021
19 Nov 2021
30 Sept 2021
18 Nov 2021
12 Oct 2021
6 Oct 2021
Hepatitis B Immunoglobulin HBIG 100 IU Technical specification 1. Each injection contains hepatitis B Immunoglobulin 100 IU 2. Number of ml per vial: 0.5 ml 3. Should be licensed under the provisions of drugs and cosmetics act and rules. 4. The product insert must indicate dosage form (intramuscular injection) and the drug content. The product should conform to standards of IP or any other pharmacopeia. 5. The label must indicate clearly the manufacturing and the expiry date. General specifications 1. Standard shelf life: atleast 18 months at the place of dispatch to the consignee. 2. Primary container: one vial/pre-filled syringe with 0.5 ml. 3. Label: It should be glazed label in accordance with the statutory requirements as per drug and cosmetic Act. The standard color of the label as approved by NVHCP should be used. Each label should have clearly marked as “ Government of India supply, not for sale” on primary packaging. The packaging and labeling requirements must meet the GMP practices. 4. It should be tested negative for HBV, HIV, HCV which will be printed on each unit packet.
Reliance Life Sciences Pvt. Ltd.
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .